OmiX Labs

OmiX Labs Develops Non-Toxic Technology on Disposable Kits for Detecting Infectious Pathogen DNA from Direct Blood or Urine (Depending on Infection Type)OmiX Labs has developed non-toxic technology on disposable kits to detect infectious pathogen DNA from direct blood or urine, depending on the type of infection. This method amplifies the pathogen’s DNA to enable faster detection in a temperature-stable manner. This type of testing, known as molecular diagnostics, applies molecular biology to medical tests, analyzing DNA, RNA, and other markers for diagnosing and monitoring diseases. The OmiX Labs solution is currently being tested and validated in multiple hospitals in southern India and has the potential to transform the landscape of diagnostic testing across the entire healthcare field. This could mean faster and more accurate treatment to reduce the risk of patient complications and mortality.In addition to identifying pathogenic pathogens more quickly and efficiently, they are also expanding their platform to address antibiotic resistance. They use molecular mechanisms to examine genetic signatures from pathogens to identify mutations and resistance to certain powerful antibiotics, which are often the last line of defense in ICU settings. They continue to develop this technology to streamline processes, making them more accurate and faster.